Johnson & Johnson Share Price Xetra

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Xetra 16:35:46 03/07/2024 BST After market 19:48:50
134.4 EUR -1.50% Intraday chart for Johnson & Johnson 135.4 +0.73%

Financials

Sales 2024 * 88.75B 82.31B 6,969B Sales 2025 * 92.26B 85.57B 7,245B Capitalization 351B 326B 27,597B
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 3.96 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 3.81 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 131,900
Yield 2024 *
3.3%
Yield 2025 *
3.45%
Free-Float 77.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.78%
1 week-2.17%
Current month-1.88%
1 month-1.13%
3 months-6.49%
6 months-9.02%
Current year-5.17%
More quotes
1 week
133.90
Extreme 133.9
138.16
1 month
133.00
Extreme 133
139.46
Current year
132.78
Extreme 132.78
150.10
1 year
132.78
Extreme 132.78
161.20
3 years
132.78
Extreme 132.78
178.26
5 years
104.12
Extreme 104.12
178.26
10 years
72.55
Extreme 72.55
178.26
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 31/12/88
Director of Finance/CFO 57 31/12/97
Chief Tech/Sci/R&D Officer 58 04/11/19
Members of the board TitleAgeSince
Director/Board Member 70 24/04/19
Director/Board Member 72 18/06/14
Director/Board Member 70 21/10/09
More insiders
Date Price Change Volume
03/07/24 134.4 -1.50% 2 668
02/07/24 136.4 -0.03% 13,566
01/07/24 136.5 -0.37% 4,030
28/06/24 137 +0.13% 1,078
27/06/24 136.8 -0.42% 1,227

Delayed Quote Xetra, July 03, 2024 at 04:35 pm

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
146 USD
Average target price
171.7 USD
Spread / Average Target
+17.59%
Consensus